Arkolith/Insider Trading/INO/Form 4

Shea Jacqueline Elizabeth

Chief Executive Officer, DirectorINOVIO PHARMACEUTICALS, INC. (INO) · full profile →Form 4 · filed May 21, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 20, 2026Option exercise(M)28K——123K
May 20, 2026Tax withholding(F)12K$1.23$15K111K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 20, 2026Option exercise(M)28K—$057K
May 20, 2026Grant(A)124K—$0124K
May 20, 2026Grant(A)100K—$0100K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001771498-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML